Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Our Event History
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Upcoming Events
    • Past Events
      • World Stem Cell Summit
      • Regenerative Medicine and Stem Cell Action Awards
      • Regenerative Medicine Essentials
      • The “Art of Science” Inspires Students
      • Exploring Public Policy: Regenerative Medicine and Cell Therapies
      • Congressional Briefings
      • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
  • Donate
Select Page
California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients

California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients

by admin | Jan 18, 2018 | News & Opinions

January 18, 2018 – Oakland, CA Over 650,000 Americans suffer from end-stage kidney disease – a life-threatening condition caused by the loss of kidney function. The best available treatment for these patients is a kidney transplant from a genetically...

Recent Posts

  • UC Berkeley researchers discover ancestor of gene-editing tool CRISPR
  • Could Inhaled Cell Therapy Change the Course of COPD?
  • Healthspan Action Coalition and Leading Italian Organizations Announce Global Collaboration
  • Launching “Healthspan for All” at the Translational Longevity Summit
  • 3D-printed spheroids enable dual bone and vascular tissue development
Tweets about @WSCSummit